Teradyne director Marilyn Matz sells $270,264 in common stock

Director Marilyn Matz of Teradyne, Inc. sold 800 shares of the company’s common stock on September 15, 2026, for a total of $270,264, at a price of $337.83 per share. This sale, conducted under a Rule 10b5-1 trading plan adopted in February 2026, occurred as the stock price was 26% lower than its current level, marking a decline over the past six months.

Despite this, Teradyne remains undervalued according to InvestingPro’s analysis and holds a strong financial health score with a perfect Piotroski Score of 9. Following the transaction, Matz holds 14,240.675 shares of Teradyne common stock. The article also highlights Teradyne’s strong financial performance in Q3 2026, with non-GAAP earnings surpassing expectations and significant revenue growth driven by AI-related demand.

In addition, Jefferies initiated coverage on Teradyne with a buy rating and a price target of $284.00, anticipating increased market share due to growth in the automated test equipment sector.

Brief written by urgent.news from Investing.com's own syndicated text. Machine-written — may contain errors; check the original before relying on it.